Invesco S&P 500 Equal Weight Health Care ETF
$36.91−0.28 (−0.77%)
- Expense ratio
- 0.40%
- Fund size
- $859M
- 1Y return
- +29.2%
- Yield · Last 12 months
- 0.60%
- Holdings
- 61
- Volume · 30D
- 0.1M sh
- NAV per share
- $36.86
- 52W range
The ETF.net RSPH Grade
Score 66 of 100 sits in the B band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.BScore 58Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.AScore 76Category rankRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.AScore 74Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.BScore 64Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.AScore 85Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.BScore 68Category rank
Our read on RSPH
BHealth care without the mega-cap gravity: RSPH gives every health care name in the S&P 500 the same slice, so no single drug giant steers the fund. It has been running that way since 2006.
The Fund seeks to track the investment results of the S&P 500 Equal Weight Health Care Index.
Why people hold it
- Equal weighting by design: about 60 S&P 500 health care names, each with the same slice, so one blockbuster drugmaker doesn't set the tone for the basket.
- Charges 0.40% a year, below the 0.50% typical of broad health care ETFs.
- Live since 2006, through drug-pricing fights, patent cliffs and a pandemic, and rated one of the stronger builds in its health care peer group.
- Spread is the point: the portfolio is one of the best-diversified in the cohort, with weight split across the sector rather than parked in a few giants.
Worth knowing
- The big cap-weighted rivals cost far less: XLV and FHLC charge 0.08%, VHT 0.09%. You're paying up for the equal-weight tilt.
- Equal weight leans toward the sector's smaller members, so results can drift from cap-weighted health care funds in either direction.
- One sector, one set of risks: policy shifts, pricing rules and patent cycles move the whole basket at once.
RSPH Holdings
- Stocks
- 61
- 23%
- MRNA
Sectors
- Health Care97.5%
- Technology2.4%
- Financials0.1%
Geography
- United States96.80%
- Ireland3.20%
RSPH Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
RSPH$12,921
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | RSPH |
|---|---|
| Year to date | +17.4% |
| 1 month | −1.4% |
| 3 months | +18.8% |
| 1 year | +29.2% |
| 3 years | +11.3% |
| 5 years | +4.5% |
| 10 years | +9.6% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | RSPH |
|---|---|---|
| 2026 YTD | +17.4% | |
| 2025 | +9.5% | |
| 2024 | −0.9% | |
| 2023 | +3.9% | |
| 2022 | −9.4% | |
| 2021 | +23.2% | |
| 2020 | +18.8% |
RSPH in the news
RSPH Dividends
- 0.60%
- $0.22
- $0.05 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Sep 21, 2026 | Pays Sep 25, 2026 | $0.05 |
| Jun 22, 2026 | Jun 26, 2026 | $0.06 |
| Mar 23, 2026 | Mar 27, 2026 | $0.06 |
| Dec 22, 2025 | Dec 26, 2025 | $0.05 |
| Sep 22, 2025 | Sep 26, 2025 | $0.06 |
| Jun 23, 2025 | Jun 27, 2025 | $0.06 |
| Mar 24, 2025 | Mar 28, 2025 | $0.06 |
| Dec 23, 2024 | Dec 27, 2024 | $0.06 |
| Sep 23, 2024 | Sep 27, 2024 | $0.05 |
| Jun 24, 2024 | Jun 28, 2024 | $0.05 |
| Mar 18, 2024 | Mar 22, 2024 | $0.05 |
| Dec 18, 2023 | Dec 22, 2023 | $0.05 |
RSPH Risk
- 16.1%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.37
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −21.9%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.79
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
RSPH Cost
0.40%
RSPH0.40%
- The middle half of Health Care (Broad) funds
- Median 0.50%
10 of the 25 Health Care (Broad) funds charge less.